Nalls Sherbakoff Group, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Nalls Sherbakoff Group, LLC

  • $112 Billion
  • Q4 2023

A detailed history of Nalls Sherbakoff Group, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 317 shares of XBI stock, worth $28,121. This represents 0.03% of its overall portfolio holdings.

Number of Shares
317
Previous 250 26.8%
Holding current value
$28,121
Previous $18.3 Million 55.02%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024
BUY
$64.12 - $90.86 $4,296 - $6,087
67 Added 26.8%
317 $28.3 Million
Q4 2018

Feb 15, 2019
BUY
N/A
225 Added 900.0%
250 $18,000
Q4 2018

Feb 13, 2019
BUY
N/A
25 New
25 $21,000

Others Institutions Holding XBI

# of Institutions
913
Shares Held
102M
Call Options Held
27.4M
Put Options Held
38.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email